Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Liver Cirrhosis and Minimal Encephalopathy: a Single Center Placebo Control Double Blind Study (PORTOALEGRE)

NCT00896831 Phase 4 UNKNOWN

The study aimed to assess the effectiveness and safety of L-ornithine-L-aspartate in the management of hepatic encephalopathy.

Details

Lead sponsor	Hospital de Clinicas de Porto Alegre
Phase	Phase 4
Status	UNKNOWN
Enrolment	96
Start date	2008-11
Completion	2010-09

Conditions

• Hepatic Encephalopathy

Interventions

• L-ornithine-L-aspartate
• placebo

Primary outcomes

• Psychometric tests and critical flicker frequency — day 0, 15, 30, 45 and 60

Countries

Brazil